2024
The European psychiatric association (EPA) – early career psychiatrists committee survey on trainees’ and early-career psychiatrists’ attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment
Schoretsanitis G, Correll C, Agorastos A, Sanchez A, Erzin G, Grigoras R, Benussi M, Gondek T, Guloksuz S, Højlund M, Jerotic S, Kilic O, Metaj E, Sidhu D, Skandali N, Skuhareuski A, Tveito M, Wolthusen R, Communication and Publications E, Chumakov E, de Filippis R. The European psychiatric association (EPA) – early career psychiatrists committee survey on trainees’ and early-career psychiatrists’ attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment. The World Journal Of Biological Psychiatry 2024, 25: 342-351. PMID: 38905131, DOI: 10.1080/15622975.2024.2367138.Peer-Reviewed Original ResearchConceptsEuropean Psychiatric AssociationAntipsychotic treatmentPsychiatrists' attitudesTherapeutic drug monitoringEarly-career psychiatristsExploratory factor analysisBenefit of therapeutic drug monitoringPsychiatric AssociationAntipsychoticsNegative expectationsAssociated with frequencyTDM useDrug monitoringTherapeutic drug monitoring useFactor analysisBeliefs of patientsHigh-income countriesLow-/middle-income countriesResponse varianceClinical benefitClozapineOutpatient settingLinear regression analysisClinical settingPsychiatrists
2023
Coping and sleep quality in youth: An Experience Sampling study
Hagemann N, Kirtley O, Lafit G, Vancampfort D, Wampers M, Decoster J, Derom C, Gülöksüz S, De Hert M, Jacobs N, Menne‐Lothmann C, Rutten B, Thiery E, van Os J, van Winkel R, Wichers M, Myin‐Germeys I. Coping and sleep quality in youth: An Experience Sampling study. Journal Of Adolescence 2023, 95: 566-583. PMID: 36647754, DOI: 10.1002/jad.12137.Peer-Reviewed Original ResearchMeSH KeywordsAdaptation, PsychologicalAdolescentEcological Momentary AssessmentHumansSleepSleep QualitySurveys and QuestionnairesConceptsEmotion-focused copingExperience Sampling StudySleep qualityDaily sleep qualitySample of youthLocus of controlSampling studyUtrecht Coping ListPassive reactionNegative eventsDaily lifeFuture insomniaCopingSleep problemsQuality of sleepMental wellMental healthDisengagementYouthState locusIndividual presentStyleDecreased sleep qualitySleepPsychopathology
2021
Medication strategies in first episode psychosis patients: A survey among psychiatrists
Kikkert M, Veling W, de Haan L, Begemann M, de Koning M, Sommer I, de Haan L, Veling W, van Os J, Smit F, Begemann M, Schuite‐Koops S, Marcelis M, Kikkert M, van Beveren N, Boonstra N, Rosema B, Bakker P, Gülöksüz S, Lokkerbol J, Brand B, Gangadin S, Geraets C, Hag E, Oomen P, Voppel A, van Amelsvoort T, Bak M, Been A, van den Bosch M, van den Brink T, Faber G, Grootens K, de Jonge M, Knegtering H, Kurkamp J, Mahabir A, Pijnenborg G, Staring T, Vaes W, Veen N, Veerman S, Wiersma S, Sommer I. Medication strategies in first episode psychosis patients: A survey among psychiatrists. Early Intervention In Psychiatry 2021, 16: 139-146. PMID: 33754470, PMCID: PMC9292219, DOI: 10.1111/eip.13138.Peer-Reviewed Original ResearchMeSH KeywordsAntipsychotic AgentsHumansPsychiatryPsychotic DisordersRemission InductionSurveys and QuestionnairesConceptsFirst psychotic episodeMedication discontinuationMedication strategiesPsychotic episodeFirst-episode psychosis patientsEpisode psychosis patientsSubstantial practice variationFirst-episode patientsMonths of remissionFirst-episode psychosisSpecific treatment strategiesSubsample of patientsPractice of cliniciansMaintenance therapyEarly discontinuationPsychosis patientsAntipsychotic drugsEpisode psychosisTreatment strategiesReduced dosePractice variationLong-term effectsSame doseDiscontinuationMost guidelines
2020
The jumping to conclusions reasoning bias as a cognitive factor contributing to psychosis progression and persistence: findings from NEMESIS-2
Rauschenberg C, Reininghaus U, Have M, de Graaf R, van Dorsselaer S, Simons C, Gunther N, Henquet C, Pries L, Guloksuz S, Bak M, van Os J. The jumping to conclusions reasoning bias as a cognitive factor contributing to psychosis progression and persistence: findings from NEMESIS-2. Psychological Medicine 2020, 51: 1696-1703. PMID: 32174291, PMCID: PMC8327623, DOI: 10.1017/s0033291720000446.Peer-Reviewed Original Research
2019
Evidence for interaction between genetic liability and childhood trauma in the development of psychotic symptoms
Pinckaers F, Rotee I, Nwosu C, Krolinski P, Smeets A, Gülöksüz S, de Jong L, Vaessen T, Damen T, Uittenboogaard A, Schäfer A, Menne-Lothmann C, Decoster J, van Winkel R, Collip D, Delespaul P, De Hert M, Derom C, Thiery E, Jacobs N, Wichers M, Rutten B, van Os J, Drukker M. Evidence for interaction between genetic liability and childhood trauma in the development of psychotic symptoms. Social Psychiatry And Psychiatric Epidemiology 2019, 54: 1045-1054. PMID: 31209522, DOI: 10.1007/s00127-019-01711-z.Peer-Reviewed Original ResearchMeSH KeywordsAdultChildChild AbuseEmotionsFemaleGenetic Predisposition to DiseaseHumansMalePsychotic DisordersRisk FactorsSurveys and QuestionnairesSymptom AssessmentConceptsChildhood traumaGenetic liabilityImpact of CTSymptom Checklist-90 scoresMixed-effects linear regression analysisSubthreshold psychotic experiencesChildhood Trauma Questionnaire-Short FormExpression of psychosisGeneral population twinsQuestionnaire-Short FormPsychosis expressionMultilevel mixed-effects linear regression analysesRisk factorsPsychotic symptomsSymptom subscalesLinear regression analysisSubthreshold expressionTotal scoreStatistical significancePsychic Experience (CAPE) questionnaireRegression analysisAffective Temperament and Seasonality in Bipolar Disorder.
Altınbaş K, İnce B, Gülöksüz S. Affective Temperament and Seasonality in Bipolar Disorder. Psychiatria Danubina 2019, 31: 106-110. PMID: 30948697, DOI: 10.24869/psyd.2019.106.Peer-Reviewed Original ResearchConceptsBipolar disorderIllness courseSeasonal Pattern Assessment QuestionnaireAffective temperamentsAnxious temperament scoresAssessment QuestionnaireEuthymic patientsTemperament scoresAffective temperament scoresTotal scoreMood regulationVersion scalePatientsScoresFurther investigationDisordersCourse
2015
Pharmaceutical industry interactions of psychiatric trainees from 20 European countries
Riese F, Guloksuz S, Roventa C, Fair J, Haravuori H, Rolko T, Flynn D, Giacco D, Banjac V, Jovanovic N, Bayat N, Palumbo C, Rusaka M, Kilic O, Augėnaitė J, Nawka A, Zenger M, Kekin I, Wuyts P, Barrett E, Bausch-Becker N, Mikaliūnas J, del Valle E, Feffer K, Lomax G, Marques J, Jauhar S. Pharmaceutical industry interactions of psychiatric trainees from 20 European countries. European Psychiatry 2015, 30: 284-290. PMID: 25456156, DOI: 10.1016/j.eurpsy.2014.09.417.Peer-Reviewed Original Research
2014
Clinical Features of Night Eating Syndrome among Depressed Patients
Kucukgoncu S, Tek C, Bestepe E, Musket C, Guloksuz S. Clinical Features of Night Eating Syndrome among Depressed Patients. European Eating Disorders Review 2014, 22: 102-108. PMID: 24436087, DOI: 10.1002/erv.2280.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAnxiety DisordersBody Mass IndexCircadian RhythmDepressionFeeding and Eating DisordersFeeding BehaviorFemaleHumansInterviews as TopicMaleMiddle AgedObesityPersonality InventoryPrevalencePsychiatric Status Rating ScalesQuality of LifeRegression AnalysisSocioeconomic FactorsStress, PsychologicalSurveys and QuestionnairesSyndromeYoung AdultConceptsPittsburgh Sleep Quality IndexBeck Depression InventoryBeck Anxiety InventoryClinical featuresDepressed patientsDepression InventoryNon-NE patientsNight eating syndromeSleep Quality IndexSample of patientsAnxiety InventorySeverity of anxietyNight Eating QuestionnaireSocio-demographic formSmoking statusDaytime dysfunctionSleep qualityDepressed outpatientsPatientsSyndromeEating QuestionnaireStudy sampleBMISignificant differencesDepression
2013
Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability
Guloksuz S, Wichers M, Kenis G, Russel M, Wauters A, Verkerk R, Arts B, van Os J. Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability. PLOS ONE 2013, 8: e60435. PMID: 23544139, PMCID: PMC3609785, DOI: 10.1371/journal.pone.0060435.Peer-Reviewed Original ResearchMeSH KeywordsAdultAffectCrohn DiseaseDepressionFatigueFemaleHumansImmunityMaleQuality of LifeReference ValuesSurveys and QuestionnairesTime FactorsTryptophanTumor Necrosis Factor-alphaConceptsCrohn's diseaseDisease activityImmune activationDepressive symptomsDepression scoresTrp availabilityΑ treatmentTryptophan availabilityNegative APPsAnti-tumor necrosis factorPast depressive disorderTNF-α treatmentSymptoms of depressionQuality of lifeCD patientsIBDQ scoreImmune markersComorbid depressionDepressive disorderNecrosis factorInflammatory reactionPatientsSymptomsDiseaseTreatment
2012
Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?
Jauhar S, Guloksuz S, Andlauer O, Lydall G, Marques J, Mendonca L, Dumitrescu I, Roventa C, De Vriendt N, Van Zanten J, Riese F, Nwachukwu I, Nawka A, Psaras R, Masson N, Krishnadas R, Volpe U, European Federation of Psychiatric Trainees' Research Group. Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence? BMC Psychiatry 2012, 12: 27. PMID: 22463055, PMCID: PMC3337226, DOI: 10.1186/1471-244x-12-27.Peer-Reviewed Original ResearchConceptsSecond-generation antipsychoticsCognitive behavioral therapyUse of SGAsSecond-generation antipsychotic medicationsKnowledge of trialQuestionnaire-based studyAntipsychotic medicationAntipsychotic treatmentTreatment choicePatientsBehavioral therapyForms of psychotherapyOwn treatmentAntipsychoticsTreatmentPsychosisTrialsPsychiatry traineesEfficacyTrainees
2009
Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians.
Gülöksüz S, Oral E, Ulaş H. Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians. Turkish Journal Of Psychiatry 2009, 20: 236-42. PMID: 19757223.Peer-Reviewed Original ResearchConceptsPharmaceutical representativesPrescribing practicesSecond-year residentsHospital staffState hospital staffPhysician prescribing practicesPsychiatry residentsUniversity hospital staffBehavior of physiciansMost physiciansPharmaceutical promotionEducational meetingsDuration of residencyPhysiciansBehaviors of psychiatristsOlder residentsPsychiatristsSignificant interaction